Search - tctmd.com

Displaying 201 - 220 of 237

Sort: Relevancy | Date

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

Presentation TCT 2014

When to Consider Septal Reduction Therapy

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann

September 16, 2014

Presentation TCT 2014

Sudden Cardiac Death and Atrial Fibrillation in HCM

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Kishore J. Harjai

September 16, 2014

Presentation TCT 2014

Hemodynamics of Dynamic Obstruction

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, James B. Hermiller Jr

September 16, 2014

Presentation TCT 2014

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Rod H. Stables

September 16, 2014

Presentation TCT 2014

Epidemiology and Genetics

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Carolyn Ho

September 16, 2014

Presentation TCT 2014

Transcatheter Repair vs Replacement for Functional Mitral Regurgitation: Competitive or Complementary (and Predictions for the Future)

Presenter: Howard C. Herrmann, Spencer H. Kubo, Karl-Heinz Kuck

September 15, 2014

Presentation TCT 2014

Experience with MitraClip in Advanced Heart Failure

Presenter: Howard C. Herrmann, Spencer H. Kubo, Anita Asgar

September 15, 2014

Presentation TCT 2014

Functional Mitral Regurgitation as a Target for Heart Failure Therapy: Patient Selection and Expected Benefits

Presenter: Howard C. Herrmann, Spencer H. Kubo, Blase A. Carabello

September 15, 2014

Presentation TCT 2014

TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure

Presenter: Howard C. Herrmann, Spencer H. Kubo, Sami Alnasser

September 15, 2014

Presentation TCT 2014

Heart Failure Before and After TAVR

Presenter: Howard C. Herrmann, Spencer H. Kubo, Stefan Sack

September 15, 2014

Presentation TCT 2014

Changing Roles and Opportunities for the Cardiac Surgeon in the TAVR Era

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Vinod H. Thourani

September 13, 2014

Presentation TCT 2014

Evolution of the Heart Valve Team Concept in the Maturation Phase of TAVR

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Ganesh Manoharan

September 13, 2014

Presentation TCT 2014

Reflections on Transcatheter Aortic Valve Therapies from BAV to TAVR: Greatest Disappointments, Surprises, and Achievements

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Alain G. Cribier

September 13, 2014

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

Presentation TCT 2013

The Evolving Role of Structural Heart Interventions in Clinical Practice: Looking Five Years into the Future

Presenter: Howard Herrmann

October 30, 2013

News Conference News TCT 2013

Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

Which Aortic Stenosis Patients Are Too High-Risk for TAVR?

Presenter: Howard Herrmann

October 27, 2013

Presentation TCT 2013

Therapy Pathways

Presenter: Howard Herrmann

October 27, 2013

Advertisement

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

When to Consider Septal Reduction Therapy

Sudden Cardiac Death and Atrial Fibrillation in HCM

Hemodynamics of Dynamic Obstruction

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Epidemiology and Genetics

Transcatheter Repair vs Replacement for Functional Mitral Regurgitation: Competitive or Complementary (and Predictions for the Future)

Experience with MitraClip in Advanced Heart Failure

Functional Mitral Regurgitation as a Target for Heart Failure Therapy: Patient Selection and Expected Benefits

TCT 690: Safety and Efficacy of Urgent Transcatheter Aortic Valve Replacement in Patients Admitted with Decompensated Heart Failure

Heart Failure Before and After TAVR

Changing Roles and Opportunities for the Cardiac Surgeon in the TAVR Era

Evolution of the Heart Valve Team Concept in the Maturation Phase of TAVR

Reflections on Transcatheter Aortic Valve Therapies from BAV to TAVR: Greatest Disappointments, Surprises, and Achievements

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

The Evolving Role of Structural Heart Interventions in Clinical Practice: Looking Five Years into the Future

Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Which Aortic Stenosis Patients Are Too High-Risk for TAVR?

Therapy Pathways

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content